CD44 and CD24 have been suggested as suitable markers for the identification of breast cancer stem cells, whereby the phenotype of tumorigenic mammary tumor cells was determined as CD44+/CD24−/low [37]. This evidence concerns the gene CD24 and breast carcinoma.